Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126639923 | 12663992 | 3 | F | 20160727 | 20160905 | 20160818 | 20160913 | EXP | PT-JNJFOC-20160811888 | JANSSEN | 77.00 | YR | E | M | Y | 0.00000 | 20160913 | CN | PT | PT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126639923 | 12663992 | 1 | SS | XARELTO | RIVAROXABAN | 1 | Oral | Y | N | 0 | 15 | MG | TABLET | BID | |||||
| 126639923 | 12663992 | 2 | PS | XARELTO | RIVAROXABAN | 1 | Oral | Y | N | 22406 | 15 | MG | TABLET | QD | |||||
| 126639923 | 12663992 | 3 | SS | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | Unknown | Y | 0 | 75 | MG | UNSPECIFIED | |||||||
| 126639923 | 12663992 | 4 | SS | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | Unknown | Y | 0 | 75 | MG | UNSPECIFIED | |||||||
| 126639923 | 12663992 | 5 | C | NEBILET | NEBIVOLOL | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 126639923 | 12663992 | 6 | C | ZARATOR | ATORVASTATIN CALCIUM | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 126639923 | 12663992 | 7 | C | COVERSYL | PERINDOPRIL | 1 | Unknown | 0 | 5 | MG | UNSPECIFIED | QD | |||||||
| 126639923 | 12663992 | 8 | C | LASIX | FUROSEMIDE | 1 | Unknown | 0 | 20 | MG | UNSPECIFIED | QD | |||||||
| 126639923 | 12663992 | 9 | C | INSULIN | INSULIN NOS | 1 | Unknown | EVENING | 0 | 18 | IU | UNSPECIFIED | |||||||
| 126639923 | 12663992 | 10 | C | GLIMEPIRIDE. | GLIMEPIRIDE | 1 | Unknown | 0 | 1 | MG | UNSPECIFIED | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126639923 | 12663992 | 1 | Thrombophlebitis |
| 126639923 | 12663992 | 2 | Thrombophlebitis |
| 126639923 | 12663992 | 3 | Hypertension |
| 126639923 | 12663992 | 4 | Venous thrombosis |
| 126639923 | 12663992 | 5 | Hypertension |
| 126639923 | 12663992 | 6 | Hypertension |
| 126639923 | 12663992 | 7 | Hypertension |
| 126639923 | 12663992 | 8 | Hypertension |
| 126639923 | 12663992 | 9 | Type 2 diabetes mellitus |
| 126639923 | 12663992 | 10 | Type 2 diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126639923 | 12663992 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126639923 | 12663992 | Diabetes mellitus inadequate control | |
| 126639923 | 12663992 | Gingival bleeding | |
| 126639923 | 12663992 | Haemoglobin decreased | |
| 126639923 | 12663992 | Loss of consciousness | |
| 126639923 | 12663992 | Malaise | |
| 126639923 | 12663992 | Off label use | |
| 126639923 | 12663992 | Small intestinal haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126639923 | 12663992 | 1 | 20160727 | 20160805 | 0 | |
| 126639923 | 12663992 | 2 | 20160805 | 0 | ||
| 126639923 | 12663992 | 3 | 20160727 | 0 | ||
| 126639923 | 12663992 | 4 | 20160727 | 0 |